Printer Friendly

Dr. Reddy's unveils OTC Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg ERTablets in the US.

M2 EQUITYBITES-November 21, 2014-Dr. Reddy's unveils OTC Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg ERTablets in the US

(C)2014 M2 COMMUNICATIONS http://www.m2.com

Pharmaceutical company Dr. Reddy's Laboratories (NYSE:RDY) disclosed on Thursday the introduction of its US FDA approved over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg in a 20 count blister in the US market.

The company added the OTC Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg is the bioequivalent generic version of Allegra-D 12 Hour Allergy & Congestion.

According to IRI, Allegra-D 12 Hour brand has US sales of about USD49.8m for the latest 52 weeks ending 6 October 2014 for Total US Multi Outlet.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2014 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Nov 21, 2014
Words:135
Previous Article:Kuka reaches 80.5% in Swisslog.
Next Article:Advanced Emissions Solutions announces lease of another Refined Coal facility to an existing RC investor.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters